We are live on
!
Find out more
CP
Catalys Pacific Portfolio holdings
AUM
$231M
1-Year Est. Return
83.19%
This Fund
S&P 500
This Quarter
Est. Return
-25.9%
1 Year Est. Return
+83.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$79.8M
(-26%)
Cap. Flow
+$819K
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phathom Pharmaceuticals
PHAT
|
+$819K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
YCM
PWA
MIM
RF
ERFOTCOFW
CBOA
WF
PBC
Catalys Pacific's Q1 2026 Portfolio in Review
As of Q1 2026, Catalys Pacific held 2 positions worth $231M, down 26% from $311M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Catalys Pacific added most to Phathom Pharmaceuticals in Q1 2026, an estimated $819K increase.
- Catalys Pacific's ten largest holdings make up 100% of its $231M portfolio in Q1 2026.
- Catalys Pacific opened 0 new positions and closed 0 in Q1 2026.
- Catalys Pacific's portfolio value fell 26% quarter-over-quarter to $231M.
Based on Catalys Pacific's 13F filing for Q1 2026, filed 14 May 2026.